| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Jefferies analyst Brian Tanquilut maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $485 to $525.
UBS analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $495 to $525.
B of A Securities analyst Joanna Gajuk maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $...
Goldman Sachs analyst Scott Fidel maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $470 to $...
TD Cowen analyst Ryan Langston maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $380 to $490.
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $449 ...
Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $445 to $...
Stephens & Co. analyst Raj Kumar maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from...